Roivant Sciences (ROIV) Gross Profit (2020 - 2025)
Roivant Sciences (ROIV) posted Gross Profit of $4.8 million for Q4 2025, up 227.05% on a QoQ basis from $1.5 million in Q3 2025, and down 77.02% year-over-year from $20.8 million in Q4 2024.
Roivant Sciences (ROIV) Gross Profit (2020 - 2025) Analysis & Trends
Roivant Sciences' Gross Profit history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- Quarterly Gross Profit fell 77.02% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.0 million (down 47.3% YoY) and the FY2026 annual result came in at $7.0 million, down 75.21% from the prior year.
- Gross Profit was $4.8 million for Q4 2025 at Roivant Sciences, up from $1.5 million in the prior quarter.
- Across five years, Gross Profit topped out at $37.6 million in Q4 2021 and bottomed at $1.5 million in Q3 2025.
- A 5-year average of $11.5 million and a median of $7.6 million in 2021 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2021 — Gross Profit surged 1150.99% — and 2025, when it tumbled 77.02%.
- Roivant Sciences' Gross Profit stood at $37.6 million in 2021, then plunged by 33.56% to $25.0 million in 2022, then decreased by 10.66% to $22.3 million in 2023, then declined by 6.79% to $20.8 million in 2024, then tumbled by 77.02% to $4.8 million in 2025.
- Business Quant data shows ROIV's Gross Profit at $4.8 million in Q4 2025, $1.5 million in Q3 2025, and $2.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.78 Mn |
| Dec 31, 2025 | 4.78 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Dec 31, 2024 | 20.78 Mn |
| Dec 31, 2024 | 20.78 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Sep 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 7.78 Mn |
| Jun 30, 2024 | 7.78 Mn |
| Dec 31, 2023 | 22.29 Mn |
| Dec 31, 2023 | 22.29 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 17.41 Mn |
| Jun 30, 2023 | 17.41 Mn |
| Dec 31, 2022 | 24.95 Mn |
| Dec 31, 2022 | 24.95 Mn |